
Advancing Monoclonal Antibody Innovation and Pandemic Preparedness with Marc Elia of Invivyd
17.07.2025
0:00
15:41
In this episode, Marc Elia, Chairperson of the Board at Invivyd, discusses his personal experience with COVID-19 and long COVID, the company’s unique monoclonal antibody platform, and how Invivyd is working to address persistent gaps in infectious disease prevention and care. He also highlights the importance of patient voices in regulatory processes and the future of scalable, accessible monoclonal antibody therapies.
This episode is sponsored by Invivyd.
Więcej odcinków z kanału "Becker’s Healthcare Podcast"
Nie przegap odcinka z kanału “Becker’s Healthcare Podcast”! Subskrybuj bezpłatnie w aplikacji GetPodcast.